Back to RA CAPITAL MANAGEMENT, L.P.FDMT
FDMTShowing 8 of 12 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in 4D MOLECULAR THERAPEUTICS IN
RA CAPITAL MANAGEMENT, L.P. holds 5M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $47M as of 2026-Q1. The position was decreased (-10.7% shares). FDMT represents 0.5% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$47M
Current Shares
5M
Total Value Change
-$60M
Total Shares Change
-48,432
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, BlackRock Finance, Inc.